异基因造血干细胞移植后中性粒细胞减少期间循环微生物游离DNA增加
本研究采用下一代测序平台,对接受异基因造血干细胞移植(allo-HCT)患者血浆中的微生物游离DNA(mcfDNA)进行特征分析,并与健康对照血浆比较。观察性研究显示,移植后血浆总mcfDNA负荷发生变化,在移植后早期中性粒细胞减少阶段最为显著,该升高可归因于多个特定细菌分类群。在另一队列中,将血浆mcfDNA数据与匹配时间点粪便样本的16S核糖体RNA测序数据比较,在部分患者中证实源自特定微生物分类群(如肠球菌)的mcfDNA也可见于匹配的粪便样本。
要点
- allo-HCT后早期中性粒细胞减少阶段血浆总mcfDNA负荷升高最为显著。
- 该升高可归因于多个特定细菌分类群,包括韦荣球菌属、拟杆菌属和普雷沃菌属(属水平)。
- 在部分患者中,源自特定微生物分类群(如肠球菌)的mcfDNA也可见于匹配的粪便样本。
核心结论
- 异基因造血干细胞移植后血浆总mcfDNA负荷发生变化,在移植后早期中性粒细胞减少阶段最为显著,该升高可归因于多个特定细菌分类群。
- 在部分患者中,源自特定微生物分类群(如肠球菌)的mcfDNA也可见于匹配的粪便样本。
- mcfDNA定量可能为了解肠道微生物组影响全身细胞群体的机制提供新见解,并因此与癌症患者结局相关。
研究设计与样本
- 观察性研究,使用下一代测序平台对接受异基因造血干细胞移植(allo-HCT)患者系列采集的血浆样本进行微生物游离DNA(mcfDNA)特征分析,并与健康对照受试者血浆比较。
- 另有一额外患者队列,将血浆mcfDNA数据与匹配时间点采集的粪便样本16S核糖体RNA测序数据进行比较。
主要发现
- 移植后血浆总mcfDNA负荷发生变化,在移植后早期中性粒细胞减少阶段最为显著。
- 该mcfDNA升高可归因于多个特定细菌分类群,包括韦荣球菌属(Veillonella)、拟杆菌属(Bacteroides)和普雷沃菌属(Prevotella)(属水平)。
- 在部分患者中,源自特定微生物分类群(如肠球菌)的mcfDNA也可见于匹配的粪便样本。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We used a next-generation sequencing platform to characterize microbial cell-free DNA (mcfDNA) in plasma samples from patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HCT). In this observational study, we sought to characterize plasma mcfDNA in order to explore its potential association with the immunologic complications of transplantation. We compared serially collected patient samples with plasma collected from healthy control subjects. We observed changes in total mcfDNA burden in the plasma after transplantation, which was most striking during the early posttransplant neutropenic phase. This elevation could be attributed to a number of specific bacterial taxa, including Veillonella, Bacteroides, and Prevotella (genus level). For an additional cohort of patients, we compared the data of mcfDNA from plasma with 16s-ribosomal RNA sequencing data from stool samples collected at matched time points. In a number of patients, we confirmed that mcfDNA derived from specific microbial taxa (eg, Enterococcus) could also be observed in the matched stool sample. Quantification of mcfDNA may generate novel insights into mechanisms by which the intestinal microbiome influences systemic cell populations and, thus, has been associated with outcomes for patients with cancer.
引用
- Blair LM, Akhund-Zade J, Katsamakis ZA, et al. Circulating microbial cell-free DNA is increased during neutropenia after hematopoietic stem cell transplantation. Blood Adv. 2023. PMID: 37399491. doi:10.1182/bloodadvances.2023010208
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。